The Consequences of the Lockdown on Cardiovascular Diseases

Aajal, A.; Boussaadani, Badre El; Hara, Loubna; Benajiba, Chakib; Boukouk, Oussama; Benali, M.; Ouadfel, Oussama; Bendoudouch, Houssam; Zergoune, Nabil; Alkattan, Dan; Mahdi, Zaynab; Najdi, Adil; Raissouni, Z

doi:10.1016/s0735-1097(21)04491-0

Cited by 8 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the literature consulted, we have found very few studies that refer to changes in blood pressure during lockdown due to COVID-19. However, the studies published are similar to our results [ 40 , 56 ].…”

Section: Discussionsupporting

confidence: 92%

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

et al. 2022

View full text Add to dashboard Cite

In December 2019, 27 cases of pneumonia were reported in Wuhan. In 2020, the causative agent was identified as a virus called SARS-CoV-2. The disease was called “coronavirus disease 2019” (COVID-19) and was determined as a Public Health Emergency. The main measures taken to cope with this included a state of lockdown. The aim of this study was to assess how the unhealthy lifestyles that ensued influenced different parameters. A prospective study was carried out on 6236 workers in a Spanish population between March 2019 and March 2021. Anthropometric, clinical, and analytical measurements were performed, revealing differences in the mean values of anthropometric and clinical parameters before and after lockdown due to the pandemic, namely increased body weight (41.1 ± 9.9–43.1 ± 9.9), BMI (25.1 ± 4.7–25.9 ± 4.7), and percentage of body fat (24.5 ± 9.1–26.9 ± 8.8); higher total cholesterol levels, with a statistically significant increase in LDL levels and a reduction in HDL; and worse glucose levels (90.5 ± 16.4–95.4 ± 15.8). Lockdown can be concluded to have had a negative effect on health parameters in both sexes in all age ranges, causing a worsening of cardiovascular risk factors.

show abstract

Section: Discussionsupporting

confidence: 92%

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Among the included studies, the diagnosis of AF was based on electrocardiograms. Three reports were from Asia, ( 16 , 24 , 25 ) 1 from Africa, ( 20 ) 7 from Europe, ( 17 – 19 , 23 , 26 , 27 , 29 ) and 8 from America ( 14 , 15 , 21 , 22 , 28 , 30 – 32 ). Apart from 4 prospective cohort studies, ( 20 , 22 , 26 , 27 ) the remaining 15 articles were designed as retrospective cohort studies ( 14 – 19 , 21 , 23 – 25 , 28 – 32 ).…”

Section: Resultsmentioning

confidence: 99%

“…More recently, numerous epidemiological studies have shown an increased risk of AF and new-onset AF among patients with COVID-19 but have yielded inconsistent results (14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32). Moreover, accumulating literature has demonstrated that AF or new-onset AF might be significantly associated with the worst outcomes (e.g., mortality) in patients with COVID-19 (21,25,29).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis

Shao

Zhang

et al. 2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Background: Epidemiological studies have shown that atrial fibrillation (AF) is a potential cardiovascular complication of coronavirus disease 2019 (COVID-19). We aimed to perform a systematic review and meta-analysis to clarify the prevalence and clinical impact of AF and new-onset AF in patients with COVID-19.Methods: PubMed, Embase, the Cochrane Library, and MedRxiv up to February 27, 2021, were searched to identify studies that reported the prevalence and clinical impact of AF and new-onset AF in patients with COVID-19. The study was registered with PROSPERO (CRD42021238423).Results: Nineteen eligible studies were included with a total of 21,653 hospitalized patients. The pooled prevalence of AF was 11% in patients with COVID-19. Older (≥60 years of age) patients with COVID-19 had a nearly 2.5-fold higher prevalence of AF than younger (<60 years of age) patients with COVID-19 (13 vs. 5%). Europeans had the highest prevalence of AF (15%), followed by Americans (11%), Asians (6%), and Africans (2%). The prevalence of AF in patients with severe COVID-19 was 6-fold higher than in patients with non-severe COVID-19 (19 vs. 3%). Furthermore, AF (OR: 2.98, 95% CI: 1.91 to 4.66) and new-onset AF (OR: 2.32, 95% CI: 1.60 to 3.37) were significantly associated with an increased risk of all-cause mortality among patients with COVID-19.Conclusion: AF is quite common among hospitalized patients with COVID-19, particularly among older (≥60 years of age) patients with COVID-19 and patients with severe COVID-19. Moreover, AF and new-onset AF were independently associated with an increased risk of all-cause mortality among hospitalized patients with COVID-19.

show abstract

“…The rate of participation (91%) compares favourably with most health-related surveys, highlighting the high level of patient implication for this subject. Most studies or reviews that reported COVID-19-related consequences included patients with chronic diseases of the same type, mostly auto-immune/inflammatory [ 12 ], neurologic [ 13 ], oncologic [ 14 ], or cardiovascular [ 15 ]. The reason is probably hypotheses about the risk of infection or severity of COVID-19 associated with specific types of drugs (immunosuppressive and anticancer agents, corticosteroids and nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers), which has been highlighted since the beginning of the pandemic, including in the medical literature [ 16 ].…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study

Boulin¹,

Cransac²,

Maynadié³

et al. 2022

IJERPH

View full text Add to dashboard Cite

Background: We aimed to investigate the impact of the first COVID-19 lockdown on medication adherence, physician access, lifestyle behaviours, and mental health in patients with chronic conditions. Methods: A cross-sectional phone survey was conducted in 1274 housebound adults recruited from 8 regional chronic disease cohorts (CLEO CD study: NCT04390126). Results: Medication adherence was 97%; 305 (41%) patients declared that at least one scheduled visit with a physician was missed during the first lockdown. The main changes in lifestyle behaviours were deterioration in sleep time (duration and/or quality; 71%), increase in screen time (46%), and decrease in physical activity (46%). Nineteen percent experienced psychological distress (Kessler-6 score ≥ 5). An urban living place (OR, 1.76 vs. rural; 95% CI, 1.32–2.33; p = 10−4), worse self-reported mental health (OR, 1.62 vs. about the same or better; 95% CI, 1.17–2.25; p = 0.003), and a K6 score ≥ 5 (OR, 1.52 vs. <5; 95% CI, 1.05–2.21; p = 0.03) were independent factors associated with at least one unhealthy behaviour. Conclusions: Encouraging results were observed in terms of medication adherence. Caution is needed in chronic disease patients living in urban places as well as those presenting psychological distress and worse self-reported mental health to reduce unhealthy behaviours.

show abstract

The Consequences of the Lockdown on Cardiovascular Diseases

Cited by 8 publications

References 0 publications

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

Impact of COVID-19 Lockdown on Anthropometric Variables, Blood Pressure, and Glucose and Lipid Profile in Healthy Adults: A before and after Pandemic Lockdown Longitudinal Study

Prevalence of Atrial Fibrillation and Associated Mortality Among Hospitalized Patients With COVID-19: A Systematic Review and Meta-Analysis

COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study

Contact Info

Product

Resources

About